{{Rsnum
|rsid=11810574
|Gene=FMN2
|Chromosome=1
|position=240120436
|Orientation=plus
|GMAF=0.05142
|Gene_s=FMN2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 87.6 | 12.4 | 0.0
| HCB | 100.0 | 0.0 | 0.0
| JPT | 100.0 | 0.0 | 0.0
| YRI | 75.5 | 21.1 | 3.4
| ASW | 73.7 | 24.6 | 1.8
| CHB | 100.0 | 0.0 | 0.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 95.0 | 4.0 | 1.0
| LWK | 75.5 | 21.8 | 2.7
| MEX | 94.8 | 5.2 | 0.0
| MKK | 75.6 | 23.7 | 0.6
| TSI | 92.2 | 7.8 | 0.0
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23400010
  |Trait=Thiazide-induced adverse metabolic effects in hypertensive patients
  |Title=Genome-wide association analyses suggest NELL1 influences adverse metabolic response to HCTZ in African Americans.
  |RiskAllele=G
  |Pval=4E-6
  |OR=23.12
  |ORtxt=[13.34-32.9] mg/dL decrease
  |OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}